Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5450)
All Articles published online
|
May 21, 2010 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Peng RQ, Chen YB, Ding Y, Zhang R, Zhang X, Yu XJ, Zhou ZW, Zeng YX, Zhang XS. Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancer. World J Gastroenterol 2010; 16(19): 2428-2434 [PMID: 20480531 DOI: 10.3748/wjg.v16.i19.2428] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i19/2428.htm |
| Number | Citing Articles |
| 1 |
Jitka Fucikova, Irena Moserova, Linda Urbanova, Lucillia Bezu, Oliver Kepp, Isabelle Cremer, Cyril Salek, Pavel Strnad, Guido Kroemer, Lorenzo Galluzzi, Radek Spisek. Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer. Frontiers in Immunology 2015; 6 doi: 10.3389/fimmu.2015.00402
|
| 2 |
Wolf Herman Fridman, Jérôme Galon, Franck Pagès, Eric Tartour, Catheriné Sautès-Fridman, Guido Kroemer. Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates. Cancer Research 2011; 71(17): 5601 doi: 10.1158/0008-5472.CAN-11-1316
|
| 3 |
Oguz Baran, Mehmet Yigit Akgun, Ahmet Kayhan, Sevket Evran, Arif Ozbek, Goktug Akyoldas, Mustafa Yavuz Samanci, Nail Demirel, Derya Sonmez, Huriye Serin, Ayhan Kocak, Rahsan Kemerdere, Taner Tanriverdi. The association between calreticulin and glucagon-like peptide-1 expressions with prognostic factors in high-grade gliomas. Journal of Cancer Research and Therapeutics 2024; 20(1): 25 doi: 10.4103/jcrt.jcrt_1519_22
|
| 4 |
Lenka Kasikova, Iva Truxova, Isabelle Cremer, Catherine Sautes-Fridman, Oliver Kepp, Guido Kroemer, Radek Spisek, Jitka Fucikova. Tumor Immunology and Immunotherapy – Cellular Methods Part B. Methods in Enzymology 2020; 632: 15 doi: 10.1016/bs.mie.2019.05.025
|
| 5 |
Peter G. Alexander, Donald C. McMillan, James H. Park. The local inflammatory response in colorectal cancer – Type, location or density? A systematic review and meta-analysis. Cancer Treatment Reviews 2020; 83: 101949 doi: 10.1016/j.ctrv.2019.101949
|
| 6 |
Vijay Wadhwan, Arvind Venkatesh, Pooja Aggarwal, Vandana Reddy, Preeti Sharma, Suhasini Gotur Palakshappa. Impact of stromal CD45RO+ immune cells on proliferation and dedifferentiation in node-negative squamous cell carcinomas of cheek mucosa. Journal of Cancer Research and Therapeutics 2019; 15(3): 625 doi: 10.4103/jcrt.JCRT_263_16
|
| 7 |
Qilong Zhou, Wei Wu, Kaimin Jia, Guangyan Qi, Xiuzhi Susan Sun, Ping Li. Design and characterization of PROTAC degraders specific to protein N-terminal methyltransferase 1. European Journal of Medicinal Chemistry 2022; 244: 114830 doi: 10.1016/j.ejmech.2022.114830
|
| 8 |
Gregory E. Idos, Janet Kwok, Nirupama Bonthala, Lynn Kysh, Stephen B. Gruber, Chenxu Qu. The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-60255-4
|
| 9 |
Vanessa Acebes-Fernández, Alicia Landeira-Viñuela, Pablo Juanes-Velasco, Angela-Patricia Hernández, Andrea Otazo-Perez, Raúl Manzano-Román, Rafael Gongora, Manuel Fuentes. Nanomedicine and Onco-Immunotherapy: From the Bench to Bedside to Biomarkers. Nanomaterials 2020; 10(7): 1274 doi: 10.3390/nano10071274
|
| 10 |
Jitka Fucikova, Iva Truxova, Michal Hensler, Etienne Becht, Lenka Kasikova, Irena Moserova, Sarka Vosahlikova, Jana Klouckova, Sarah E. Church, Isabelle Cremer, Oliver Kepp, Guido Kroemer, Lorenzo Galluzzi, Cyril Salek, Radek Spisek. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients. Blood 2016; 128(26): 3113 doi: 10.1182/blood-2016-08-731737
|
| 11 |
Lucy Jankova, Owen F. Dent, Mark P. Molloy, Charles Chan, Pierre H. Chapuis, Viive M. Howell, Stephen J. Clarke. Reporting in studies of protein biomarkers of prognosis in colorectal cancer in relation to the REMARK guidelines. PROTEOMICS – Clinical Applications 2015; 9(11-12): 1078 doi: 10.1002/prca.201400177
|
| 12 |
Abhishek D. Garg, Dirk De Ruysscher, Patrizia Agostinis. Immunological metagene signatures derived from immunogenic cancer cell death associate with improved survival of patients with lung, breast or ovarian malignancies: A large-scale meta-analysis. OncoImmunology 2016; 5(2): e1069938 doi: 10.1080/2162402X.2015.1069938
|
| 13 |
Lei Cai, Theodoros Michelakos, Teppei Yamada, Song Fan, Xinhui Wang, Joseph H. Schwab, Cristina R. Ferrone, Soldano Ferrone. Defective HLA class I antigen processing machinery in cancer. Cancer Immunology, Immunotherapy 2018; 67(6): 999 doi: 10.1007/s00262-018-2131-2
|
| 14 |
Mayram Amiri-Shoar, Masoumeh Hosseini, Mitra Arianmanesh, Reza Eghdam-Zamiri, Shahrokh Attarian, Ali Awsat Mellati. Comparative Proteomic Analysis of Breast Cancer Tissue and the Adjacent Normal Tissue in Iranian Patients with HER2 Negative Ductal Carcinoma of Breast. International Journal of Cancer Management 2017; 10(5) doi: 10.5812/ijcm.6019
|
| 15 |
Paul Eggleton, Jorge De Alba, Michael Weinreich, Perry Calias, Roly Foulkes, Valerie M. Corrigall. The therapeutic mavericks: Potent immunomodulating chaperones capable of treating human diseases. Journal of Cellular and Molecular Medicine 2023; 27(3): 322 doi: 10.1111/jcmm.17669
|
| 16 |
Jitka Fucikova, Radek Spisek, Guido Kroemer, Lorenzo Galluzzi. Calreticulin and cancer. Cell Research 2021; 31(1): 5 doi: 10.1038/s41422-020-0383-9
|
| 17 |
Xu-Hua Zhang, Yue Zhang, Wen-Peng Xie, De-Sheng Sun, Yong-Kui Zhang, Yan-Ke Hao, Guo-Qing Tan. Expression and significance of calreticulin in human osteosarcoma. Cancer Biomarkers 2017; 18(4): 405 doi: 10.3233/CBM-160266
|
| 18 |
Adriana Petrazzuolo, Maria Perez-Lanzon, Isabelle Martins, Peng Liu, Oliver Kepp, Véronique Minard-Colin, Maria Chiara Maiuri, Guido Kroemer. Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects. Cell Death & Disease 2021; 12(8) doi: 10.1038/s41419-021-03997-x
|
| 19 |
Udo Holtick, Nela Klein-Gonzalez, Michael S von Bergwelt-Baildon. Potential of Toll-like receptor 9 agonists in combined anticancer immunotherapy strategies: synergy of PAMPs and DAMPs?. Immunotherapy 2011; 3(3): 301 doi: 10.2217/imt.10.118
|
| 20 |
Rianne D. W. Vaes, Lizza E. L. Hendriks, Marc Vooijs, Dirk De Ruysscher. Biomarkers of Radiotherapy-Induced Immunogenic Cell Death. Cells 2021; 10(4): 930 doi: 10.3390/cells10040930
|
| 21 |
Dongning He, Lei Wu, Xiaoxi Li, Xiaodan Liu, Ping Ma, Youhong Juang. Ecotropic virus integration‑1 and calreticulin as novel prognostic markers in triple‑negative breast cancer: A retrospective cohort study. Oncology Letters 2019; doi: 10.3892/ol.2019.10472
|
| 22 |
S. Martin, A.M. Dudek-Perić, H. Maes, A.D. Garg, M. Gabrysiak, S. Demirsoy, J.V. Swinnen, P. Agostinis. Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells. Biochemical Pharmacology 2015; 93(3): 290 doi: 10.1016/j.bcp.2014.12.003
|
| 23 |
Ananthan Sadagopan, Theodoros Michelakos, Gabriella Boyiadzis, Cristina Ferrone, Soldano Ferrone. Human Leukocyte Antigen Class I Antigen-Processing Machinery Upregulation by Anticancer Therapies in the Era of Checkpoint Inhibitors. JAMA Oncology 2022; 8(3): 462 doi: 10.1001/jamaoncol.2021.5970
|
| 24 |
Philipp Müller, Jonathan Rios-Doria, Jay Harper, Anthony Cao. Innovations for Next-Generation Antibody-Drug Conjugates. Cancer Drug Discovery and Development 2018; : 11 doi: 10.1007/978-3-319-78154-9_2
|
| 25 |
C.S.D. Roxburgh, D.C. McMillan. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer. Cancer Treatment Reviews 2012; 38(5): 451 doi: 10.1016/j.ctrv.2011.09.001
|
| 26 |
Laurence Zitvogel, Oliver Kepp, Guido Kroemer. Immune parameters affecting the efficacy of chemotherapeutic regimens. Nature Reviews Clinical Oncology 2011; 8(3): 151 doi: 10.1038/nrclinonc.2010.223
|
| 27 |
Melanie J. McCoy, Anna K. Nowak, Richard A. Lake. Cell Death Signaling in Cancer Biology and Treatment. 2013; : 373 doi: 10.1007/978-1-4614-5847-0_14
|
| 28 |
Ming Sun, Shanshan Qi, Min Wu, Wei Xia, Hao Xiong. Calreticulin as a prognostic biomarker and correlated with immune infiltrate in kidney renal clear cell carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.909556
|
| 29 |
Ruo Feng, Jianwen Ye, Chuang Zhou, Lei Qi, Zhe Fu, Bing Yan, Zhiwei Liang, Renfeng Li, Wenlong Zhai. Calreticulin down-regulation inhibits the cell growth, invasion and cell cycle progression of human hepatocellular carcinoma cells. Diagnostic Pathology 2015; 10(1) doi: 10.1186/s13000-015-0382-1
|
| 30 |
Gautier Stoll, Kristina Iribarren, Judith Michels, Alexandra Leary, Laurence Zitvogel, Isabelle Cremer, Guido Kroemer. Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer. OncoImmunology 2016; 5(7): e1177692 doi: 10.1080/2162402X.2016.1177692
|
| 31 |
Tina Riedel, Olivier Demaria, Olivier Zava, Ana Joncic, Michel Gilliet, Paul J. Dyson. Drug Repurposing Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma Treatment. Molecular Pharmaceutics 2018; 15(1): 116 doi: 10.1021/acs.molpharmaceut.7b00764
|
| 32 |
David A. Bernal-Estévez, Oscar García, Ramiro Sánchez, Carlos A. Parra-López. Monitoring the responsiveness of T and antigen presenting cell compartments in breast cancer patients is useful to predict clinical tumor response to neoadjuvant chemotherapy. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-017-3982-1
|
| 33 |
Abhishek D. Garg, Dmitri V. Krysko, Peter Vandenabeele, Patrizia Agostinis. DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown. Photochemical & Photobiological Sciences 2011; 10(5): 670 doi: 10.1039/c0pp00294a
|
| 34 |
Paul Eggleton, Edwin Bremer, Elzbieta Dudek, Marek Michalak. Calreticulin, a therapeutic target?. Expert Opinion on Therapeutic Targets 2016; 20(9): 1137 doi: 10.1517/14728222.2016.1164695
|
| 35 |
Nicole Rufo, Abhishek D. Garg, Patrizia Agostinis. The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy. Trends in Cancer 2017; 3(9): 643 doi: 10.1016/j.trecan.2017.07.002
|
| 36 |
Seng-Ryong Woo, Leticia Corrales, Thomas F. Gajewski. Innate Immune Recognition of Cancer. Annual Review of Immunology 2015; 33(1): 445 doi: 10.1146/annurev-immunol-032414-112043
|
| 37 |
Mladen Korbelik, Wei Zhang, Soroush Merchant. Involvement of damage-associated molecular patterns in tumor response to photodynamic therapy: surface expression of calreticulin and high-mobility group box-1 release. Cancer Immunology, Immunotherapy 2011; 60(10): 1431 doi: 10.1007/s00262-011-1047-x
|
| 38 |
Lenka Kasikova, Michal Hensler, Iva Truxova, Petr Skapa, Jan Laco, Lucie Belicova, Ivan Praznovec, Sarka Vosahlikova, Michael J. Halaska, Tomas Brtnicky, Lukas Rob, Jiri Presl, Jan Kostun, Isabelle Cremer, Ales Ryska, Guido Kroemer, Lorenzo Galluzzi, Radek Spisek, Jitka Fucikova. Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0781-z
|
| 39 |
Ke Zhu, Wen Deng, Hui Deng, Xiaoqiang Liu, Gongxian Wang, Bin Fu, Hongbao Cao. Identification of a Novel PPAR Signature for Predicting Prognosis, Immune Microenvironment, and Chemotherapy Response in Bladder Cancer. PPAR Research 2021; 2021: 1 doi: 10.1155/2021/7056506
|
| 40 |
Abhishek D. Garg, Sanne Elsen, Dmitri V. Krysko, Peter Vandenabeele, Peter de Witte, Patrizia Agostinis. Resistance to anticancer vaccination effect is controlled by a cancer cell-autonomous phenotype that disrupts immunogenic phagocytic removal. Oncotarget 2015; 6(29): 26841 doi: 10.18632/oncotarget.4754
|
| 41 |
Guido Kroemer, Lorenzo Galluzzi, Oliver Kepp, Laurence Zitvogel. Immunogenic Cell Death in Cancer Therapy. Annual Review of Immunology 2013; 31(1): 51 doi: 10.1146/annurev-immunol-032712-100008
|
| 42 |
Binbin Du, Xiaoying Wang, Dewang Wu, Tao Wang, Xiongfei Yang, Jiankai Wang, Xinlong Shi, Lingjuan Chen, Weisheng Zhang. MicroRNA expression profiles identify biomarkers for predicting the response to chemoradiotherapy in rectal cancer. Molecular Medicine Reports 2018; doi: 10.3892/mmr.2018.9215
|
| 43 |
Kate Wilkinson, Weng Ng, Tara Laurine Roberts, Therese M Becker, Stephanie Hui-Su Lim, Wei Chua, Cheok Soon Lee. Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancer. Journal of Clinical Pathology 2021; 74(10): 625 doi: 10.1136/jclinpath-2020-207309
|
| 44 |
Chih-Jung Chen, Ya-Chuan Hu, Yueh Chien, Wei-Chieh Huang, Chi-Sheng Wu, Chung-Ying Tsai, Yang-Hsiang Lin, Meng-Shiue Lee, Chian-Shiu Chien, Yi-Ping Yang, Meng-Chou Lee, Chung-Chih Tseng, Hsiang-Cheng Chi, Alexandros Georgakilas. Calreticulin Expression Controls Cellular Redox, Stemness, and Radiosensitivity to Function as a Novel Adjuvant for Radiotherapy in Neuroblastoma. Oxidative Medicine and Cellular Longevity 2023; 2023: 1 doi: 10.1155/2023/8753309
|
| 45 |
Shubhankar Nath, Girgis Obaid, Tayyaba Hasan. The Course of Immune Stimulation by Photodynamic Therapy: Bridging Fundamentals of Photochemically Induced Immunogenic Cell Death to the Enrichment of T‐Cell Repertoire. Photochemistry and Photobiology 2019; 95(6): 1288 doi: 10.1111/php.13173
|
| 46 |
Zuzanna Kanduła, Krzysztof Lewandowski. Calreticulin – a multifaced protein. Postępy Higieny i Medycyny Doświadczalnej 2021; 75(1): 328 doi: 10.5604/01.3001.0014.8892
|
| 47 |
Sylvain Ladoire, Laura Senovilla, David Enot, François Ghiringhelli, Vichnou Poirier-Colame, Kariman Chaba, Gulsun Erdag, Jochen T. Schaefer, Donna H. Deacon, Laurence Zitvogel, Craig L. Slingluff, Guido Kroemer. Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate. OncoImmunology 2016; 5(6): e1160193 doi: 10.1080/2162402X.2016.1160193
|
| 48 |
T Colangelo, G Polcaro, P Ziccardi, L Muccillo, M Galgani, B Pucci, M Rita Milone, A Budillon, M Santopaolo, G Mazzoccoli, G Matarese, L Sabatino, V Colantuoni. The miR-27a-calreticulin axis affects drug-induced immunogenic cell death in human colorectal cancer cells. Cell Death & Disease 2016; 7(2): e2108 doi: 10.1038/cddis.2016.29
|
| 49 |
A D Garg, E Romano, N Rufo, P Agostinis. Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation. Cell Death & Differentiation 2016; 23(6): 938 doi: 10.1038/cdd.2016.5
|
| 50 |
Matthew P. Rausch, Aparna Ranganathan Sertil. A Stressful Microenvironment: Opposing Effects of the Endoplasmic Reticulum Stress Response in the Suppression and Enhancement of Adaptive Tumor Immunity. International Reviews of Immunology 2015; 34(2): 104 doi: 10.3109/08830185.2015.1018415
|
| 51 |
Xiaoli Liu, Bin Yan, Yao Li, Xiaowei Ma, Wangbo Jiao, Kejian Shi, Tingbin Zhang, Shizhu Chen, Yuan He, Xing-Jie Liang, Haiming Fan. Graphene Oxide-Grafted Magnetic Nanorings Mediated Magnetothermodynamic Therapy Favoring Reactive Oxygen Species-Related Immune Response for Enhanced Antitumor Efficacy. ACS Nano 2020; 14(2): 1936 doi: 10.1021/acsnano.9b08320
|
| 52 |
Weiwei Sheng, Guosen Wang, Jingtong Tang, Xiaoyang Shi, Rongxian Cao, Jian Sun, Yi Heng Lin, Chao Jia, Chuanping Chen, Jianping Zhou, Ming Dong. Calreticulin promotes EMT in pancreatic cancer via mediating Ca2+ dependent acute and chronic endoplasmic reticulum stress. Journal of Experimental & Clinical Cancer Research 2020; 39(1) doi: 10.1186/s13046-020-01702-y
|
| 53 |
Shuai Han, Qinghe Wang, Mingquan Shen, Xingpeng Zhang, Jian Wang. Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma. Heliyon 2024; 10(6): e27630 doi: 10.1016/j.heliyon.2024.e27630
|
| 54 |
M. De Silva, B. C. Y. Tse, C. I. Diakos, S. Clarke, M. P. Molloy. Immunogenic cell death in colorectal cancer: a review of mechanisms and clinical utility. Cancer Immunology, Immunotherapy 2024; 73(3) doi: 10.1007/s00262-024-03641-5
|
| 55 |
Giada Gelsomino, Paola A Corsetto, Ivana Campia, Gigliola Montorfano, Joanna Kopecka, Barbara Castella, Elena Gazzano, Dario Ghigo, Angela M Rizzo, Chiara Riganti. Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition. Molecular Cancer 2013; 12(1) doi: 10.1186/1476-4598-12-137
|
| 56 |
Yi-Jun Wang, Rochelle Fletcher, Jian Yu, Lin Zhang. Immunogenic effects of chemotherapy-induced tumor cell death. Genes & Diseases 2018; 5(3): 194 doi: 10.1016/j.gendis.2018.05.003
|
| 57 |
Barbara Ziffels, Anna Grötsch, Lubna Al-Bayati, Dario Neri. Targeted delivery of calreticulin to ED-A fibronectin leads to tumor-growth retardation. Journal of Biotechnology 2019; 290: 53 doi: 10.1016/j.jbiotec.2018.12.007
|
| 58 |
Alfonso Serrano-del Valle, Alberto Anel, Javier Naval, Isabel Marzo. Immunogenic Cell Death and Immunotherapy of Multiple Myeloma. Frontiers in Cell and Developmental Biology 2019; 7 doi: 10.3389/fcell.2019.00050
|
| 59 |
Heng Yang, Yuting Ma, Guo Chen, Heng Zhou, Takahiro Yamazaki, Christophe Klein, Federico Pietrocola, Erika Vacchelli, Sylvie Souquere, Allan Sauvat, Laurence Zitvogel, Oliver Kepp, Guido Kroemer. Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy. OncoImmunology 2016; 5(6): e1149673 doi: 10.1080/2162402X.2016.1149673
|
| 60 |
Carolin Muth, Yvonne Rubner, Sabine Semrau, Paul-Friedrich Rühle, Benjamin Frey, Annedore Strnad, Rolf Buslei, Rainer Fietkau, Udo S. Gaipl. Primary glioblastoma multiforme tumors and recurrence. Strahlentherapie und Onkologie 2016; 192(3): 146 doi: 10.1007/s00066-015-0926-z
|
| 61 |
Jonathan M. Pitt, Guido Kroemer, Laurence Zitvogel. Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy. Advances in Experimental Medicine and Biology 2017; 1036: 65 doi: 10.1007/978-3-319-67577-0_5
|
| 62 |
Alexandra M. Mowday, Jella M. van de Laak, Zhe Fu, Kimiora L. Henare, Ludwig Dubois, Philippe Lambin, Jan Theys, Adam V. Patterson. Tumor-targeting bacteria as immune stimulants – the future of cancer immunotherapy?. Critical Reviews in Microbiology 2024; : 1 doi: 10.1080/1040841X.2024.2311653
|
| 63 |
Jitka Fucikova, Lenka Kasikova, Iva Truxova, Jan Laco, Petr Skapa, Ales Ryska, Radek Spisek. Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer. Immunology Letters 2018; 193: 25 doi: 10.1016/j.imlet.2017.11.006
|
| 64 |
Alfonso Serrano Del Valle, Manuel Beltrán-Visiedo, Victoria de Poo-Rodríguez, Nelia Jiménez-Alduán, Gemma Azaceta, Rosana Díez, Beatriz Martínez-Lázaro, Isabel Izquierdo, Luis Palomera, Javier Naval, Alberto Anel, Isabel Marzo. Ecto-calreticulin expression in multiple myeloma correlates with a failed anti-tumoral immune response and bad prognosis. OncoImmunology 2022; 11(1) doi: 10.1080/2162402X.2022.2141973
|
| 65 |
Olga Vaksman, Ben Davidson, Claes Tropé, Reuven Reich. Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastases. Human Pathology 2013; 44(12): 2677 doi: 10.1016/j.humpath.2013.07.009
|
| 66 |
Sedigheh Naseri, Mariela Mejia Cordova, Jessica Wenthe, Tanja Lövgren, Emma Eriksson, Angelica Loskog, Gustav J. Ullenhag. CD40 stimulation via CD40 ligand enhances adenovirus‐mediated tumour immunogenicity including ‘find‐me’, ‘eat‐me’, and ‘kill‐me’ signalling. Journal of Cellular and Molecular Medicine 2024; 28(7) doi: 10.1111/jcmm.18162
|
| 67 |
Oliver Kepp, Peng Liu, Liwei Zhao, Isabelle Plo, Guido Kroemer. Surface-exposed and soluble calreticulin: conflicting biomarkers for cancer prognosis. OncoImmunology 2020; 9(1) doi: 10.1080/2162402X.2020.1792037
|
| 68 |
T Colangelo, G Polcaro, P Ziccardi, B Pucci, L Muccillo, M Galgani, A Fucci, M R Milone, A Budillon, M Santopaolo, C Votino, M Pancione, A Piepoli, G Mazzoccoli, M Binaschi, M Bigioni, C A Maggi, M Fassan, C Laudanna, G Matarese, L Sabatino, V Colantuoni. Proteomic screening identifies calreticulin as a miR-27a direct target repressing MHC class I cell surface exposure in colorectal cancer. Cell Death & Disease 2016; 7(2): e2120 doi: 10.1038/cddis.2016.28
|
| 69 |
Darina Ocadlikova, Mariangela Lecciso, Alessandro Isidori, Federica Loscocco, Giuseppe Visani, Sergio Amadori, Michele Cavo, Antonio Curti. Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01004
|
| 70 |
Maria Lie Lotsberg, Sandy Chen, Sushil Dhakal, James B. Lorens, Bruce Baguley, Salem Chouaib, Agnete S.T. Engelsen. Autophagy in Immune Response: Impact on Cancer Immunotherapy. 2020; : 119 doi: 10.1016/B978-0-12-819609-0.00008-0
|
| 71 |
Kuo-Ching Mei, Nagasri Thota, Pu-Sheng Wei, Bofang Yi, Emily E. Bonacquisti, Juliane Nguyen. Calreticulin P-domain-derived “Eat-me” peptides for enhancing liposomal uptake in dendritic cells. International Journal of Pharmaceutics 2024; 653: 123844 doi: 10.1016/j.ijpharm.2024.123844
|